End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7.5 CNY | +0.40% | -3.60% | -26.69% |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
Strengths
- Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company does not generate enough profits, which is an alarming weak point.
- With an expected P/E ratio at 53.57 and 7.18 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-26.69% | 25Cr | - | ||
+2.46% | 10TCr | A- | ||
-8.98% | 6.08TCr | A- | ||
+74.76% | 4.87TCr | B | ||
+13.97% | 3.85TCr | B | ||
+4.56% | 3.17TCr | A- | ||
+14.72% | 2.05TCr | B- | ||
+11.17% | 1.68TCr | C+ | ||
+8.81% | 1.41TCr | B- | ||
-3.19% | 1.34TCr | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 300839 Stock
- Ratings Ningbo Bohui Chemical Technology Co.,Ltd